Inhibition of NF-κB nuclear translocation via HO-1 activation underlies α-tocopheryl succinate toxicity

Journal of Nutritional Biochemistry

Volumn 23, Issue 12, 2012, Pages 1583-1591

  Bellezza, Ilaria ^a   Tucci, Arianna ^a   Galli, Francesco ^a   Grottelli, Silvia ^a   Mierla, Anna Lisa ^a   Pilolli, Francesca ^a   Minelli, Alba ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Cystine glutamic acid exchange transporter; Glutathione; Heme oxygenase 1; NF B; Nrf2; Reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; ELECTROPHILE; GLUTATHIONE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; BINDING AFFINITY; CANCER CELL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROSTATE CANCER; RAT; UPREGULATION; WESTERN BLOTTING;

ALPHA-TOCOPHEROL; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; GLUTATHIONE; HEME OXYGENASE-1; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NF-E2-RELATED FACTOR 2; NF-KAPPA B; PROSTATIC NEOPLASMS; PROTEIN TRANSPORT; REACTIVE OXYGEN SPECIES;

TOSCANA VIRUS;

EID: 84869081486     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.10.012     Document Type: Article

References (48)

1. Neuzil J., Weber T., Schröder A., Lu M., Ostermann G., Gellert N., et al. Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements. FASEB J 2001, 15:403-415.
2. Prasad K.N., Kumar B., Yan X.D., Hanson A.J., Cole W.C. Alpha-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: a review. J Am Coll Nutr 2003, 22:108-117.
3. Weber T., Lu M., Andera L., Lahm H., Gellert N., Fariss M.W., et al. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. Clin Cancer Res. 2002, 8:863-869.
4. Galli F., Stabile A.M., Betti M., Conte C., Pistilli A., Rende M., et al. The effect of alpha- and gamma-tocopherol and their carboxyethyl hydroxychroman metabolites on prostate cancer cell proliferation. Arch Biochem Biophys 2004, 423:97-102.
5. Neuzil J., Dyason J.C., Freeman R., Dong L.F., Prochazka L., Wang X.F., et al. Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II. J Bioenerg Biomembr 2007, 39:65-72.
6. Dong L.F., Low P., Dyason J.C., Wang X.F., Prochazka L., Witting P.K., et al. Alpha-tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II. Oncogene 2008, 27:4324-4335.
7. Dong L.F., Freeman R., Liu J., Zobalova R., Marin-Hernandez A., Stantic M., et al. Suppression of tumor growth in vivo by the mitocan alpha-tocopheryl succinate requires respiratory complex II. Clin Cancer Res 2009, 15:1593-1600.
8. Dos Santos G.A., Abreu E., Lima R.S., Pestana C.R., Lima A.S., Scheucher P.S., et al. (+)α-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex I and is as effective as arsenic trioxide or ATRA against acute promyelocytic leukemia in vivo. Leukemia 2011, 10.1038/leu.2011.216.
9. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999, 13:76-86.
10. Minelli A., Conte C., Grottelli S., Bellezza I., Emiliani C., Bolaños J.P. Cyclo(His-Pro) up-regulates heme oxygenase 1 via activation of Nrf2-ARE signalling. J Neurochem 2009, 111:956-966.
11. Minelli A., Conte C., Grottelli S., Bellezza M., Cacciatore I., Bolaños J.P. Cyclo(His-Pro) promotes cytoprotection by activating Nrf2-mediated up-regulation of antioxidant defence. J Cell Mol Med 2009, 13:1149-1161.
12. Jozkowicz A., Was H., Dulak J. Heme oxygenase-1 in tumors: is it a false friend?. Antioxid Redox Signal 2007, 9:2099-2117.
13. Prawan A., Kundu J.K., Surh Y.J. Molecular basis of heme oxygenase-1 induction: implications for chemoprevention and chemoprotection. Antioxid Redox Signal 2005, 7:1688-16703.
14. Sacca P., Meiss R., Casas G., Mazza O., Calvo J.C., Navone N., et al. Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer. Br J Cancer 2007, 97:1683-1689.
15. Karin M., Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005, 5:749-759.
16. Dejardin E. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem Pharmacol 2006, 72:1161-1179.
17. Bellezza I., Mierla A.L., Minelli A. Nrf2 and NF-κB and their concerted modulation in cancer pathogenesis and progression. Cancers 2010, 2:483-497.
18. Jin W., Wang H., Yan W., Xu L., Wang X., Zhao X., et al. Disruption of Nrf2 enhances upregulation of nuclear factor-kappaB activity, proinflammatory cytokines, and intercellular adhesion molecule-1 in the brain after traumatic brain injury. Mediators Inflamm 2008, 2008:725174.
19. Brigelius-Flohé R., Flohé L. Basic principles and emerging concepts in the redox control of transcription factors. Antioxid Redox Signal 2011, [Epub ahead of print].
20. Cronauer M.V., Eder I.E., Hittmair A., Sierek G., Hobisch A., Culig Z., et al. A reliable system for the culture of human prostatic cells. In Vitro Cell Dev Biol Anim 1997, 33:742-744.
21. Galli F., Benedetti S., Buoncristiani U., Piroddi M., Conte C., Canestrari F., et al. The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels. Kidney Int 2003, 64:748-755.
22. Eruslanov E., Kusmartsev S. Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol Biol 2010, 594:57-72.
23. Minelli A., Bellezza I., Conte C., Culig Z. Oxidative stress-related aging: a role for prostate cancer?. Biochim Biophys Acta 2009, 1795:83-91.
24. Rigas B., Sun Y. Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer. Br J Cancer 2008, 98:1157-1160.
25. Gloire G., Legrand-Poels S., Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 2006, 72:1493-1505.
26. Crispen P.L., Uzzo R.G., Golovine K., Makhov P., Pollack A., Horwitz E.M., et al. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention. Prostate 2007, 67:582-590.
27. Palayoor S.T., Youmell M.Y., Calderwood S.K., Coleman C.N., Price B.D. Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene 1999, 18:7389-7394.
28. Gasparian A.V., Yao Y.J., Lü J., Yemelyanov A.Y., Lyakh L.A., Slaga T.J., et al. Selenium compounds inhibit I kappa B kinase (IKK) and nuclear factor-kappa B (NF-kappa B) in prostate cancer cells. Mol Cancer Ther 2002, 1:1079-1087.
29. Fariss M.W., Fortuna M.B., Everett C.K., Smith J.D., Trent D.F., Djuric Z. The selective antiproliferative effects of alpha-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds. Cancer Res 1994, 4:3346-3351.
30. Israel K., Yu W., Sanders B.G., Kline K. Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis. Nutr Cancer. 2000, 36:90-100.
31. Fariss M.W., Nicholls-Grzemski F.A., Tirmenstein M.A., Zhang J.G. Enhanced antioxidant and cytoprotective abilities of vitamin E succinate is associated with a rapid uptake advantage in rat hepatocytes and mitochondria. Free Radic Biol Med 2001, 31:530-541.
32. Prochazka L., Dong L.F., Valis K., Freeman R., Ralph S.J., Turanek J., et al. alpha-Tocopheryl succinate causes mitochondrial permeabilization by preferential formation of Bak channels. Apoptosis 2010, 15:782-794.
33. Weber T., Dalen H., Andera L., Nègre-Salvayre A., Augé N., Sticha M., et al. Mitochondria play a central role in apoptosis induced by alpha-tocopheryl succinate, an agent with antineoplastic activity: comparison with receptor-mediated pro-apoptotic signaling. Biochemistry 2003, 42:4277-4291.
34. Shiau C.W., Huang J.W., Wang D.S., Weng J.R., Yang C.C., Lin C.H., et al. alpha-Tocopheryl succinate induces apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 function. J Biol Chem 2006, 281:11819-11825.
35. Yu W., Sanders B.G., Kline K. RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Cancer Res 2003, 63:2483-2491.
36. D'Alessio M., De Nicola M., Coppola S., Gualandi G., Pugliese L., Cerella C., et al. Oxidative Bax dimerization promotes its translocation to mitochondria independently of apoptosis. FASEB J 2005, 19:1504-1506.
37. Hayes J.D., McMahon M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci 2009, 34:176-188.
38. Galli F. Interactions of polyphenolic compounds with drug disposition and metabolism. Curr Drug Metab 2007, 8:830-838.
39. Kang Y.H., Lee E., Youk H.J., Kim S.H., Lee H.J., Park Y.G., et al. Potentiation by alpha-tocopheryl succinate of the etoposide response in multidrug resistance protein 1-expressing glioblastoma cells. Cancer Lett 2005, 217:181-190.
40. Khanduja K.L., Kumar S., Varma N., Varma S.C., Avti P.K., Pathak C.M. Enhancement in alpha-tocopherol succinate-induced apoptosis by all-trans-retinoic acid in primary leukemic cells: role of antioxidant defense, Bax and c-myc. Mol Cell Biochem 2008, 319:133-139.
41. Lee J.M., Calkins M.J., Chan K., Kan Y.W., Johnson J.A. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem 2003, 278:12029-12038.
42. Qiang W., Kuang X., Liu J., Liu N., Scofield V.L., Reid A.J., et al. Astrocytes survive chronic infection and cytopathic effects of the ts1 mutant of the retrovirus Moloney murine leukemia virus by upregulation of antioxidant defenses. J Virol 2006, 80:3273-3284.
43. Dalen H., Neuzil J. Alpha-tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-kappaB activation. Br J Cancer 2003, 88:153-158.
44. Erl W., Weber C., Wardemann C., Weber P.C. alpha-Tocopheryl succinate inhibits monocytic cell adhesion to endothelial cells by suppressing NF-kappa B mobilization. Am J Physiol 1997, 273:H634-H640.
45. Qanungo S., Starke D.W., Pai H.V., Mieyal J.J., Nieminen A.L. Glutathione supplementation potentiates hypoxic apoptosis by S-glutathionylation of p65-NFkappaB. J Biol Chem 2007, 282:18427-18436.
46. Banning A., Brigelius-Flohé R. NF-kappaB, Nrf2, and HO-1 interplay in redox-regulated VCAM-1 expression. Antioxid Redox Signal 2005, 7:889-899.
47. Liao B.C., Hsieh C.W., Liu Y.C., Tzeng T.T., Sun Y.W., Wung B.S. Cinnamaldehyde inhibits the tumor necrosis factor-alpha-induced expression of cell adhesion molecules in endothelial cells by suppressing NF-kappaB activation: effects upon IkappaB and Nrf2. Toxicol Appl Pharmacol 2008, 229:161-171.
48. Gibbs P.E., Maines M.D. Biliverdin inhibits activation of NF-kappaB: reversal of inhibition by human biliverdin reductase. Int J Cancer 2007, 121:2567-2574.